Edith A. Perez - Dec 22, 2021 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role: Chief Medical Officer
Signature: /s/ William P. Quinn, Attorney-in-Fact
Stock symbol: BOLT
Transactions as of: Dec 22, 2021
Transactions value $: $117,174
Form type: 4
Date filed: 2/1/2022, 06:18 PM
Next filing: Feb 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BOLT	Common Stock	Purchase	$15.3K	+917		$16.65^*	917	Jun 4, 2021	Direct	F1
transaction	BOLT	Common Stock	Purchase	$1.91K	+411	+44.82%	$4.64	1.33K	Dec 6, 2021	Direct	F1
transaction	BOLT	Common Stock	Options Exercise	$100K	+35.7K	+2689.31%	$2.80	37K	Dec 22, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BOLT	Stock Option (Right to Buy)	Options Exercise	$0	-35.7K	-15.87%	$0.00	189K	Dec 22, 2021	Common Stock	35.7K	$2.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
F2	1/4th of the shares subject to the option shall vest on the one year anniversary of April 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider through each such date.